PF-05175157

DB12096InvestigationalSmall molecule

PF-05175157 has been used in trials studying the basic science and treatment of Acne Vulgaris, Diabetes Mellitus, Type 2 Diabetes Mellitus, Diabetes Mellitus Type 2, and Diabetes Mellitus, Type 2,...

Formula / weight: C₂₃H₂₇N₅O₂ · 405.502 g/mol (avg)
Code names: PF-05175157

Resolves to

Compound

UNIIP826WR56FICAS1301214-47-0ChEMBLCHEMBL3359265PubChem52934180

Structure

InChIKeyBDXXSFOJPYSYOC-UHFFFAOYSA-NSMILESCC(C)N1N=CC2=C1C(=O)CC1(CCN(CC1)C(=O)C1=CC=C3N=C(C)NC3=C1)C2

Targets

O00763ACACB

What you can answer from here — as of April 02, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

5Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with PF-05175157, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account